Axsome Therapeutics Statistics
Total Valuation
AXSM has a market cap or net worth of $5.46 billion. The enterprise value is $5.37 billion.
Important Dates
The last earnings date was Monday, August 4, 2025, before market open.
| Earnings Date | Aug 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AXSM has 49.90 million shares outstanding. The number of shares has increased by 2.92% in one year.
| Current Share Class | 49.90M |
| Shares Outstanding | 49.90M |
| Shares Change (YoY) | +2.92% |
| Shares Change (QoQ) | +1.17% |
| Owned by Insiders (%) | 1.37% |
| Owned by Institutions (%) | 70.97% |
| Float | 38.95M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 10.77 |
| Forward PS | 7.08 |
| PB Ratio | 74.57 |
| P/TBV Ratio | 315.53 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 10.85 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.57, with a Debt / Equity ratio of 2.97.
| Current Ratio | 1.57 |
| Quick Ratio | 1.47 |
| Debt / Equity | 2.97 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -24.62 |
Financial Efficiency
Return on equity (ROE) is -280.68% and return on invested capital (ROIC) is -44.47%.
| Return on Equity (ROE) | -280.68% |
| Return on Assets (ROA) | -21.90% |
| Return on Invested Capital (ROIC) | -44.47% |
| Return on Capital Employed (ROCE) | -69.92% |
| Revenue Per Employee | $724,792 |
| Profits Per Employee | -$361,493 |
| Employee Count | 683 |
| Asset Turnover | 0.83 |
| Inventory Turnover | 2.51 |
Taxes
| Income Tax | -875,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +28.82% in the last 52 weeks. The beta is 0.51, so AXSM's price volatility has been lower than the market average.
| Beta (5Y) | 0.51 |
| 52-Week Price Change | +28.82% |
| 50-Day Moving Average | 105.92 |
| 200-Day Moving Average | 105.33 |
| Relative Strength Index (RSI) | 58.87 |
| Average Volume (20 Days) | 634,161 |
Short Selling Information
The latest short interest is 3.67 million, so 7.36% of the outstanding shares have been sold short.
| Short Interest | 3.67M |
| Short Previous Month | 3.63M |
| Short % of Shares Out | 7.36% |
| Short % of Float | 9.43% |
| Short Ratio (days to cover) | 5.85 |
Income Statement
In the last 12 months, AXSM had revenue of $495.03 million and -$246.90 million in losses. Loss per share was -$5.06.
| Revenue | 495.03M |
| Gross Profit | 452.85M |
| Operating Income | -208.15M |
| Pretax Income | -309.56M |
| Net Income | -246.90M |
| EBITDA | -199.64M |
| EBIT | -208.15M |
| Loss Per Share | -$5.06 |
Full Income StatementBalance Sheet
The company has $303.02 million in cash and $217.31 million in debt, giving a net cash position of $85.71 million or $1.72 per share.
| Cash & Cash Equivalents | 303.02M |
| Total Debt | 217.31M |
| Net Cash | 85.71M |
| Net Cash Per Share | $1.72 |
| Equity (Book Value) | 73.08M |
| Book Value Per Share | 1.47 |
| Working Capital | 194.52M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$120.63 million and capital expenditures -$471,000, giving a free cash flow of -$121.10 million.
| Operating Cash Flow | -120.63M |
| Capital Expenditures | -471,000 |
| Free Cash Flow | -121.10M |
| FCF Per Share | -$2.43 |
Full Cash Flow StatementMargins
Gross margin is 91.48%, with operating and profit margins of -42.05% and -49.88%.
| Gross Margin | 91.48% |
| Operating Margin | -42.05% |
| Pretax Margin | -50.05% |
| Profit Margin | -49.88% |
| EBITDA Margin | -40.33% |
| EBIT Margin | -42.05% |
| FCF Margin | n/a |
Dividends & Yields
AXSM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.92% |
| Shareholder Yield | -2.92% |
| Earnings Yield | -4.52% |
| FCF Yield | -2.22% |
Dividend DetailsAnalyst Forecast
The average price target for AXSM is $176.56, which is 61.40% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $176.56 |
| Price Target Difference | 61.40% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 16 |
| Revenue Growth Forecast (5Y) | 46.62% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AXSM has an Altman Z-Score of 2.48 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.48 |
| Piotroski F-Score | 4 |